Subacute Thyroiditis in the Course of Coronavirus Disease 2019: A Case Report
Abstract
Subacute thyroiditis (SAT) is a non-suppurative thyroid gland inflammation, which usually develops after viral upper respiratory tract infections, accompanied by pain and fever. Here, we present a 49-year-old Turkish man who developed SAT 10 days after the diagnosis of coronavirus disease 2019 (COVID-19). After the COVID-19 outbreak, affecting millions of people worldwide, millions of people are also likely to develop SAT. Therefore, clinicians should pay attention to the development of SAT after COVID-19. J Endocrinol Metab. 2020;10(3-4):110-112 doi: https://doi.org/10.14740/jem678
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.